Skip to content
TripleID logo

People

Team

Simon Mallal

Simon Mallal

Director

  • Major E.B. Stahlman Chair in Infectious Diseases and Inflammation, Vanderbilt University Medical Center
  • Director, Center for Translational Immunology and Infectious Diseases

Simon Mallal is a physician-scientist who holds the Major E.B. Stahlman Chair in Infectious Diseases and Inflammation at Vanderbilt University Medical Center and directs the Center for Translational Immunology and Infectious Diseases. He was the founding director of the Institute for Immunology and Infectious Diseases at Murdoch University. His collaborative research spans HLA immunogenetics, viral adaptation, drug hypersensitivity, and T-cell-mediated disease, including the discovery and clinical translation of HLA-B*57:01 screening before abacavir. He is a coauthor of the two published Keystone Epitope Theory reviews.

Elizabeth J. Phillips, MD

Elizabeth J. Phillips, MD

Director

  • John A. Oates Chair in Clinical Research, Vanderbilt University Medical Center
  • Founder and Director, Center for Drug Safety and Immunology

Elizabeth J. Phillips holds the John A. Oates Chair in Clinical Research and is Founder and Director of the Center for Drug Safety and Immunology at Vanderbilt University Medical Center. A physician-scientist trained in infectious diseases, immunology, and clinical pharmacology, she studies the genetic and cellular mechanisms of severe drug hypersensitivity. Her work has helped translate HLA-B*57:01 testing into clinical screening before abacavir and extends to single-cell investigation of severe cutaneous adverse reactions. Her Australian research career includes leadership of the Centre for Clinical Pharmacology and Infectious Diseases at Murdoch University. She is a coauthor of the clinical Keystone Epitope Theory review.

Amir Asiaee

Amir Asiaee

Computational Lead

  • Assistant Professor of Biostatistics and Biomedical Informatics, Vanderbilt University Medical Center

Amir Asiaee builds the computational pipeline behind the company’s discovery work: cross-reactivity search across viral and human proteomes, HLA-restricted binding prediction, and the statistical machinery that prioritizes candidate triplets for experimental testing. His methodological research is in causal inference and statistical learning for high-dimensional biological data, connecting molecular measurements to interpretable mechanisms in genomics and immunology.